Search

everythinglearnresearchcommunity

for

Search:↓

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Gefitinib can cause rare scarring hair loss.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

FERONIA is crucial for plant growth, pollen tube reception, and sugar signaling.

The 4C32 gene may help in mouse skin development and differentiation.

Laser-pretreated blood for hair loss treatment was more effective and increased stem cells.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

Modified rat hair follicle stem cells can help create artificial hair follicles, blood vessels, and skin.

The scraggly mutation causes hair loss and skin defects in mice.

Frontal fibrosing alopecia has occurred in two related male families.

Activin A and Follistatin affect how mouse hair follicles grow.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Kdm6b is crucial for skin cell differentiation.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

The number of CAG repeats in the androgen receptor gene doesn't significantly affect female pattern hair loss in the Han Chinese population.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

VEGFR-2 is active in hair follicles, sebaceous glands, sweat glands, and skin on the human scalp.